Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting

Atherosclerosis

Volumn 156, Issue 2, 2001, Pages 463-468

  Von Beckerath, Nicolas ^b   Koch, Werner ^a   Mehilli, Julinda ^a   Böttiger, Corinna ^a   Braun, Siegmund ^a   Schömig, Albert ^a   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Genetics; Glycoproteins; Platelets; Restenosis; Stents

Indexed keywords

INTEGRIN RECEPTOR; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; ALLELE; ANGIOGRAPHY; ARTICLE; CORONARY ARTERY; CORONARY STENT; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

AGED; BASE SEQUENCE; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; INTEGRINS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ODDS RATIO; PLATELET ADHESIVENESS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, COLLAGEN; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STENTS;

EID: 0035004040     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00686-9     Document Type: Article

References (35)

1. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow
2. Platelet receptors for collagen
3. Activation of the GP IIb-IIIa complex induced by platelet adhesion to collagen is mediated by both alpha2beta1 integrin and GP VI
4. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors
5. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion
6. Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation
7. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia
8. Platelet unresponsiveness to collagen: Involvement of glycoprotein Ia- IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder
9. Variability of integrin alpha 2 beta 1 activity on human platelets
10. Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence
11. Role of the 807 C/T polymorphism of the alpha2 gene in platelet GP Ia collagen receptor expression and function. Effect in thromboembolic diseases
12. Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density
13. Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system
14. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: A case-control study
15. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients
16. The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients
17. The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction
18. Changes in membrane glycoproteins of circulating platelets after coronary stent implantation
19. Pathology of acute and chronic coronary stenting in humans
20. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure
21. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents
22. Diabetes mellitus
23. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay
24. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for patient selection
25. Performing the exact test of Hardy-Weinberg proportion for multiple alleles
26. Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting
27. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. The EPIC investigators
28. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of platelet IIb/IIIa inhibition in stenting investigators
29. Integrin polymorphisms as risk factors for thrombosis
30. Platelet surface collagen receptor polymorphisms: Variable receptor expression and thrombotic/hemorrhagic risk
31. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis
32. PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement
33. A polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement
34. HPA-1 genotype in arterial thrombosis - Role of HPA-1b polymorphism in platelet function
35. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study